A Comparison of Aspergillus Prophylaxis with Voriconazole versus Isavuconazole in Lung Transplant Recipients

Fungal infections are an important cause of mortality and morbidity in lung transplant recipients, and Aspergillus species are the most common cause of infection. Comprehensive consensus guidelines on antifungal prophylaxis against Aspergillus infection in lung transplant recipients has not been established. There are clinical practice variations in Aspergillus prophylaxis, with regards to duration of treatment, choice of agent, and route of administration. Voriconazole is the agent mostly used as Aspergillus prophylaxis.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 268 Source Type: research